Latest Featured Products

Discover ioSensory Neurons, precision reprogrammed human iPSC-derived nociceptors from bit.bio. Don’t settle for non-human in vitro models or long, complex differentiation protocols that require toxic reagents. Start running reliable nociception assays with ioSensory Neurons today.

Label-free biosensor technologies have emerged as a promising approach to identify high-value hits with a strong likelihood of success as a therapeutic. Unlike traditional approaches of drug discovery, they are fast, sensitive, and come with improved success rates towards high-value drug candidates.

Designed with sustainability in mind, the Avio® 220 Max is a compact, hybrid simultaneous ICP-OES with multiple waste-reducing technologies.

From the quickest start-up time on the market to reduced argon consumption, the Avio 220 Max is ideal for labs with low-to-medium throughput requirements.

From raw data to report, simplify your NGS and CGH data analysis and variant interpretation with integrated bioinformatics for your translational research.

The Revio system adds affordability, high throughput, and ease of use to a foundation of long
reads, exceptional accuracy, and direct methylation detection. Get reads that are tens of
kilobases in length with >Q30 scores and complete phased genomes for <$1,000, all with 50%
fewer consumables.

CARNK cell therapies are novel therapeutic options developed with the aim to overcome some limitations of CART cell therapies, such as therapy induced side effects.

Mix and match up to 21 protein assays with 99% combinability. Each and every assay is transparently validated to the highest standards and you can be fully confident that whatever combination of assays you select will work together and deliver high quality data with excellent specificity, sensitivity, and dynamic range

Antibody drugs including monoclonal antibodies (mAb), bispecific antibodies, antibody-drug conjugates (ADCs), and nanobodies have sparked a new surge in research and development. Owing to the importance of in vitro screening and target validation during the early stages of antibody discovery, Sino Biological provides various reagents and extensive in vitro efficacy evaluation services to fulfill diverse testing needs.

Designed for ease of use, the FlowSyn Maxi™ from Uniqsis is a high throughput flow reactor for process chemists looking to optimise reaction conditions before scaling-up synthetic production to multiple kilograms per day. Combining the benefits of proven technology with the capability to run at high flow rates (up to 100 ml/min) all in a compact benchtop design – this system sets a new standard for higher throughput applications.

Sino Biological provides the most cost-effective solution for the rapid production of a large number of antibodies. In response to the rapidly increasing therapeutic needs, Sino Biological combines its expertise in gene synthesis, vector design and transient antibody expression technology to produce highly efficient antibodies in HEK293 and CHO cells in as fast as 2 weeks.